Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term clinical-trials. Found 29 abstracts

no pagination
Lee CK, Marschner IC, Simes RJ, Voysey M, Egleston B, Hudes G, de Souza P. Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus. Clinical Cancer Research. 2012 Jun;18(11):3188-96.   PMCID: Not NIH funded
Michaelson MD, Bellmunt J, Hudes GR, Goel S, Lee RJ, Kantoff PW, Stein CA, Lardelli P, Pardos I, Kahatt C, Nieto A, Cullell-Young M, Lewis NL, Smith MR. Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer. Annals of Oncology. 2012 May;23(5):1234-40.   PMCID: not NIH funded
Moore KN, Sill MW, Miller DS, McCourt C, De Geest K, Rose PG, Cardenes HR, Mannel RS, Farley JH, Schilder RJ, Fracasso PM. A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study. Gynecologic Oncology. 2012 Dec;127(3):456-61.   PMCID: *
Astsaturov IA, Meropol NJ, Alpaugh RK, Burtness BA, Cheng JD, McLaughlin S, Rogatko A, Xu ZH, Watson JC, Weiner LM, Cohen SJ. Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma. American Journal of Clinical Oncology-Cancer Clinical Trials. 2011 Feb;34(1):70-5.   PMCID: PMC3030655
Farley J, Sill MW, Birrer M, Walker J, Schilder RJ, Thigpen JT, Coleman RL, Miller BE, Rose PG, Lankes HA. Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study. Gynecologic Oncology. 2011 May;121(2):303-8.   PMCID: PMC3081894
Gulec SA, Cohen SJ, Pennington KL, Zuckier LS, Hauke RJ, Horne H, Wegener WA, Teoh N, Gold DV, Sharkey RM, Goldenberg DM. Treatment of Advanced Pancreatic Carcinoma with Y-90-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial. Clinical Cancer Research. 2011 Jun;17(12):4091-100.   PMCID: not NIH funded
Plimack ER, Hudes GR. Selecting Targeted Therapies for Patients With Renal Cell Carcinoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):997-1007.   PMCID: not NIH funded
Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Rich TA, Willett CG. Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the US Intergroup/RTOG 9704 Phase III Trial. Annals of Surgical Oncology. 2011 May;18(5):1319-26.   PMCID: NIHMS323431 [approved 10-18-12]
Van Cleave JH, Egleston BL, Bourbonniere M, McCorkle R. Combining Extant Datasets with Differing Outcome Measures Across Studies of Older Adults after Cancer Surgery. Research in Gerontological Nursing. 2011 Jan;4(1):36-46.   PMCID: PMC3263316
Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation a systematic review and meta-analysis. Tobacco Control. 2010 Oct;19(5):410-6.   PMCID: PMC2947553
Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, Giuliano A, Jones HW, Lele SM, Lieberman RW, Massad SL, Morgan MA, Reynolds RK, Rhodes HE, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S. Cervical Cancer Screening. Journal of the National Comprehensive Cancer Network. 2010 Dec;8(12):1358-86.   PMCID: not NIH funded
Movsas B, Moughan J, Sarna L, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Wasserman T, Bruner DW. Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801. Journal of Clinical Oncology. 2009 Dec;27(34):5816-22.   PMCID: PMC2793002
Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ. Patients' decision-making process regarding participation in phase I oncology research. JOURNAL OF CLINICAL ONCOLOGY. 2006 Sep;24(27):4479-84.
Klumpp TR, Herman J, Ulicny J, Emmons RV, Martin ME, Mangan KF. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION. 2006 Nov;38(9):615-20.
Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01. Journal of Clinical Oncology. 2005 Apr;23(10):2145-54.
Rogatko A, Babb JS, Tighiouart M, Khuri FR, Hudes G. New paradigm in dose-finding trials: Patient-specific dosing and beyond phase I. Clinical Cancer Research. 2005 Aug;11(15):5342-6.
Bradley J, Movsas B. Radiation esophagitis: Predictive factors and preventive strategies. Seminars in Radiation Oncology. 2004 Oct;14(4):280-6.
Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Journal of Clinical Oncology. 2004 Jul;22(14):2856-64.
Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M. Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology. 2002 Jul;224(1):47-54.
Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: Long-term follow-up of RTOG 92-04. International Journal of Radiation Oncology Biology Physics. 2002 Jul;53(3):548-57.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term clinical-trials

clinical-trials cancer radiotherapy lung-cancer carcinoma chemotherapy therapy Oncology bevacizumab radiation randomized controlled-trial concurrent concurrent chemotherapy colorectal-cancer adjuvant chemotherapy combination information cisplatin docetaxel toxicity efficacy informed-consent advanced cancer-patients transcatheter arterial chemoembolization Papanicolaou test interferon-alpha 1989 entice rl-statistics in medicine-v8-p431 biopsy pregnant smokers working group squamous-cell carcinoma therapeutic misconception 1993 horney ca-medical care-v31-p247 questionnaire qlq-c30 radiology and radiologists gemcitabine phase-iii antitumor-activity 2007 corkle r-urol nurs-v27-p65 i enrollment intraepithelial radiosensitization incompatibility human-papillomavirus type-16 breast-cancer chemoradiotherapy eortc qlq-c30 ii trial efficacy study symptomatic treatment open-label renal cell therapy oncology group young-women therapy-oncology-group randomized-trial plus gemcitabine 1989 corkle r-cancer-v64-p1375 motivation chemotherapeutic embolization plus cetuximab cancer screening oncology k-ras activation procedure mtor escalation health survey sf-36 undetermined significance phase-iii trial curative resection pancreatic adenocarcinoma dosimetric predictors metabolism experience plasma-levels carboplatin NCCN Guidelines et-743 conformal radiotherapy adenocarcinoma loop electrosurgical excision pancreaticoduodenectomy rapamycin radiation therapy intensification NCCN Clinical Practice Guidelines hyperfractionated radiation cold-knife conization 1997 ang ch-phys med rehabil sta-v11-p397 perceptions Cisplatin clinical trial coagulation hydroxyurea home care monoclonal-antibody pam4 uterine cervix radiation-therapy kidney neoplasms prognostic factors health hematopoietic stem cell transplantation monoclonal-antibody c225 lymphoma brief interventions pathology radioimmunotherapy system excision procedure refractory prostate-cancer Carcinoma quality-of-life 2010 dermott df-v28 sunitinib organ preservation adolescent smokers Transplantation percutaneous ethanol injection women mammalian target cell lung-cancer lung cancer squamous-cell-carcinoma metaanalysis atypical glandular cells health-care settings versus-host-disease growth-factor docetaxel chemotherapy-prostate cancer-second-line-trabectedin embolization angiogenesis dosimetry functional status Immunology genetics induced injury program amifostine adenocarcinoma in-situ 2-stage designs cytology Pelvic radiation Cervical cancer-Cetuximab Cervical cancer medullary regeneration survival electrosurgical Hematology
Last updated on Friday, August 14, 2020